Top

Neurological Sciences

Published in:

11-05-2022 | Myelodysplastic Syndrome | Letter to the Editor

Myelodysplastic syndrome in an alemtuzumab-treated multiple sclerosis patient

Authors: Jean Hee Kim, Silvia Park, Woojun Kim

Published in: Neurological Sciences | Issue 9/2022

Excerpt

Dear Editor-in-Chief, …

Guarnera C, Bramanti P, Mazzon E (2017) Alemtuzumab: a review of efficacy and risks in the treatment of relapsing remitting multiple sclerosis. Ther Clin Risk Manag 13:871–879. https://doi.org/10.2147/TCRM.S134398CrossRefPubMedPubMedCentral

Kim W, Kim HJ (2020) Monoclonal Antibody Therapies for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder. J Clin Neurol 16(3):355–368. https://doi.org/10.3988/jcn.2020.16.3.355CrossRefPubMedPubMedCentral

Klotz L, Meuth SG, Wiendl H (2012) Immune mechanisms of new therapeutic strategies in multiple sclerosis-A focus on alemtuzumab. Clin Immunol 142(1):25–30. https://doi.org/10.1016/j.clim.2011.04.006CrossRefPubMed

Kuendgen A, Nomdedeu M, Tuechler H, Garcia-Manero G, Komrokji RS, Sekeres MA et al (2021) Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS. Leukemia 35(3):835–849. https://doi.org/10.1038/s41375-020-0917-7CrossRefPubMed

Fox EJ, Buckle GJ, Singer B, Singh V, Boster A (2019) Lymphopenia and DMTs for relapsing forms of MS: Considerations for the treating neurologist. Neurol Clin Pract 9(1):53–63. https://doi.org/10.1212/CPJ.0000000000000567CrossRefPubMedPubMedCentral

Title: Myelodysplastic syndrome in an alemtuzumab-treated multiple sclerosis patient
Authors: Jean Hee Kim
Silvia Park
Woojun Kim
Publication date: 11-05-2022
Publisher: Springer International Publishing
Keywords: Myelodysplastic Syndrome
Multiple Sclerosis
Thrombocytopenia
Interferon
Glatiramer acetate
Dimethyl Fumarate
Alemtuzumab
Alemtuzumab
Published in: Neurological Sciences / Issue 9/2022
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-022-06124-6

At a glance: The STEP trials

Springer Medicine

Myelodysplastic syndrome in an alemtuzumab-treated multiple sclerosis patient

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 9/2022

SARS-CoV-2 vaccination, Parkinson’s disease, and other movement disorders: case series and short literature review

The pupil and myself: pupil dilation during retrieval of self-defining memories

Challenges of practicing neuro-endovascular interventions in a resource-limited country; Ghana in focus

Greater occipital nerve blockade in cluster headache: effectiveness and safety of a combined injection protocol

FDG PET in the differential diagnosis of degenerative parkinsonian disorders: usefulness of voxel-based analysis in clinical practice

Cognitive function in untreated subjects with mild hyperphenylalaninemia: a systematic review